- The PCORI Strategic Plan
- Our Programs
- Our Vision & Mission
- Financial Statements and Reports
- The PCORI Strategic Plan
- Board of Governors
- Methodology Committee
- Authorizing Law
- Evaluating Our Work
- PCORI's Advisory Panels
- Procurement Opportunities
- Patient-Centered Economic Outcomes Landscape (2023-2024)
Past Opportunities to Provide Input
- Systematic Review of Audio Care for the Management of Mental Health and Chronic Conditions (2023) -- Draft Key Questions
- Proposed New Methodology Standards for Usual Care as a Comparator (2023)
- Stakeholder Views on Components of 'Patient-Centered Value' in Health and Health Care (2023)
- PCORI's Proposed Research Agenda (2021-2022)
- Proposed National Priorities for Health (2021)
- Proposed Principles for the Consideration of the Full Range of Outcomes Data in PCORI-Funded Research (2020)
- Proposed New PCORI Methodology Standards (2018)
- Data Access and Data Sharing Policy: Public Comment (2017)
- Proposed New PCORI Methodology Standards (2017)
Comment on the Proposed New and Revised PCORI Methodology Standards (2016)
- 1. Standards for Formulating Research Questions
- 10: Standards for Studies of Diagnostic Tests
- 12. Standards on Research Designs Using Clusters
- 13: General Comments on the Proposed Revisions to the PCORI Methodology Standards
- 2: Standards Associated with Patient-Centeredness
- 3: Standards for Data Integrity and Rigorous Analysis
- 4: Standards for Preventing and Handling Missing Data
- 5: Standards for Heterogeneity of Treatment Effects
- 6: Standards for Data Registries
- 7: Standards for Data Networks as Research-Facilitating Structures
- 8. Standards for Causal Inference Methods
- 9. Standards for Adaptive Trial Designs
- Peer-Review Process Comments (2014)
- Draft Methodology Report Public Comment Period (2012)
For Immediate Release
Patient-Centered Outcomes Research Institute
WASHINGTON, DC (May 5, 2015) — The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors, at its May 4 meeting, approved $14 million for the first demonstration project to be conducted using PCORnet, the National Patient-Centered Clinical Research Network, as well as plans for two more PCORnet demonstration projects totaling up to $29.5 million in support.
The Board approved funding for a three-year clinical trial that will compare the benefits and harms of low-dose and regular-strength aspirin among patients to prevent heart attacks and strokes in patients diagnosed with heart disease. The trial will involve researchers, clinicians, and patients from six of PCORnet’s 11 Clinical Data Research Networks (CDRNs), and one of the 18 Patient-Powered Research Networks (PPRNs) will provide a secure patient portal for data collection.
The Board also approved development of a new funding announcement offering up to $7.5 million to support the participation of as many as three CDRNs in an ongoing multi-site study focused on diabetes care. The CDRNs will join five health systems participating in the Natural Experiments in Translation – for Diabetes (NEXT-D) trial funded by the U.S. Centers for Disease Control and Prevention and the National Institutes of Health. The study is assessing variations in and among health systems’ policies and clinical interventions for preventing and managing diabetes.
In addition, PCORI will develop a funding announcement offering up to $22 million to support up to nine projects designed to demonstrate the PPRNs’ ability to conduct research that addresses the concerns of their patient communities. Proposed studies must address research questions generated and approved by patient members of the networks. PCORI will fund up to eight smaller projects at $2.5 million each in total costs over three years and one study engaging multiple PPRNs at $4 million over three years.
“The demonstration projects approved by our Board provide an excellent means to both develop PCORnet’s capacities and to support comparative clinical effectiveness research that answers important questions, such as which dose of aspirin is most effective and safest and how best health systems can manage patients’ diabetes,” said Rachael Fleurence, PhD, Director of PCORI’s CER Methods and Infrastructure Program. “These demonstration studies are an important step in our efforts to transition PCORnet from its development phase into a research-ready national resource.”
PCORI is developing PCORnet to enhance the nation’s capacity to conduct much-needed health outcomes studies more quickly and efficiently, less expensively, and with greater potential impact than is now possible. PCORI invested $93.5 million in December 2013 to support the development and expansion of 29 individual health data networks that make up PCORnet. These include 11 CDRNs, based in large health systems, and 18 PPRNs, based in a range of patient groups. PCORI has offered up to $150.7 million in additional funds to support further development of PCORnet.
The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed healthcare decisions. PCORI is committed to continuously seeking input from a broad range of stakeholders to guide its work.
The Patient-Centered Outcomes Research Institute (PCORI) is an independent nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed healthcare decisions. PCORI is committed to continually seeking input from a broad range of stakeholders to guide its work.
Recent News Releases
What's Happening at PCORI?
The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.